Navigation Links
CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
Date:9/9/2009

ers are believed to play a role in behaviors like attention and movement. Much like height or eye color, ADHD can be inherited. Studies suggest that 76 percent of ADHD is linked to family genetics. So the condition is more common among people who have a close relative with ADHD. Adults with ADHD have a 50 percent chance of passing it on to their children.

About CONCERTA((R))

CONCERTA((R)) is a prescription product approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.

IMPORTANT SAFETY INFORMATION

Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.

CONCERTA((R)) should not be taken by patients who have: allergies to methylphenidate or other ingredients in CONCERTA((R)); significant anxiety, tension, or agitation; glaucoma; tics, Tourette's syndrome, or family history of Tourette's syndrome; current or past use of monoamine oxidase inhibitor (MAOI); esophagus, stomach, or intestinal narrowing. Children under 6 years of age should not take CONCERTA((R)).

Abuse of methylphenidate may lead to dependence. Tell your healthcare professional if you or your child has had problems with alcohol or drugs; has had any heart problems, heart defects, high blood pressure, or a family history of these problems; has had depression, abnormal thoughts or visions, bipolar disorder, or seizure. Contact your healthcare professional immediately if you or your child: develops abnormal thinking or hallucinations, abnormal or extreme moods and/or excessive activity; or if aggressive behavior or hostility develops or worsens while taking CONCERTA((R)). Your child's healthcare professional should check height and weight
'/>"/>

SOURCE McNeil Pediatrics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. District Court Decision Received in CONCERTA(R) Patent Case
2. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
3. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
4. ICC Launches New Elpac Brand Convection Cooled 100-Watt Open Frame Power Supply
5. Bounty Parenting Club Launches View on Demand How to Breastfeed Video
6. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
7. Fairfield, New Jersey Cosmetic Dentistry Practice Launches State-of-the-art New Website
8. National Alliance on Mental Illness (NAMI Michigan) Launches TV Awareness Campaign
9. PRC Launches New Web Resource for Teaching Language to Children & Adults with Speech Disabilities
10. Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
11. RBC Life Sciences Launches New Initiatives Aimed at Building Its Network Marketing Business Across North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Awarded American Podiatric Medical Association’s Seal of Acceptance , ... ... -- As shoppers continue their search for the perfect gift ... for items that are considered healthy for the environment. When ... many of today’s most stylish items are also healthy for ...
(Date:12/16/2009)... nationwide confidential legal consultations for users of Paxil who have ... Attempted Suicide, Suicide and Addiction Issues. Individuals suffering from Paxil ... to the firm’s website at http://www.ennislaw.com and fill ... ... (PRWEB) December 16, 2009 -- Bloomberg news reported ...
(Date:12/15/2009)... failure of the U.S. Senate to allow importation ... the more effective direct bulk purchasing of prescription ... big industry controls the health reform debate, according ... Senator Dorgan (D-ND) was a relatively modest proposal, ... Medicare to directly negotiate discounts with drug manufacturers," ...
(Date:12/15/2009)... Dec. 15 Palo Alto Networks(TM), the ... has deployed its PA-4000 Series next-generation firewalls for ... for enhanced visibility and control over applications such ... a Japanese national university with eight facilities on ... by integrating a number of academic schools and ...
(Date:12/15/2009)... area where all couples of reproductive age were evaluated, ... -- The number of children born with cystic fibrosis ... CF mutation carriers increases, a new study finds. , ... of northeast Italy for many years. Since the 1990s, ... the number of infants born with CF. , Two ...
Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2
... The ,Help is Here Express, bus tour will be ... - May 1 at various cities in order to ... that provide prescription medicines for free or nearly free. ... the Partnership for Prescription Assistance (PPA) is ready to ...
... make an appropriate decision regarding care for patients ... according to a study performed at St. Joseph,s ... included 62 patients. Results showed that, "approximately 50% ... ultrasound evaluation," said Srinivasan Harish, lead author of ...
... University School of Medicine (BUSM) have found that some ... a brief intervention. The BUSM study appears in the ... and Drugs . , "Brief intervention shows promise for ... with higher cognitive functioning or an alcohol- attributable diagnosis," ...
... High fructose corn syrup ,misunderstood,WASHINGTON, April 23 ... Williams ran a report, "The sweet truth about ... Robert Bazell. In the report, Mr. Bazell ... little difference between the two products." ( ...
... WASHINGTON, April 23 The YWCA USA applauds President Obama,s ... their time and talent to improve their local communities. ... bill and called on Americans to learn about volunteer and ... moment in history," he said. "I,m not going to tell ...
... imaging (DWI) to determine whether or not a breast ... breast biopsies, according to a study performed at the ... a method that produces images detecting the exchange of ... study included 80 patients with 85 lesions. Quantitative analysis ...
Other Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession 4Health News:Researchers find medical inpatients with unhealthy alcohol use may benefit from brief intervention 2Health News:Landmark NBC News Nutrition Report: 'There Is Indeed Little Difference Between High Fructose Corn Syrup and Table Sugar' 2Health News:YWCA USA Applauds President Obama's National Call for Volunteer Service 2
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... assessment of the competitive environment is ... management responsibilities, the task crucial to ... and factual competitive intelligence is vital ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...
(Date:12/15/2009)... Mass., Dec. 15 NxStage Medical, Inc. ... innovative dialysis products, today announced that a group ... will be embarking on a week-long, conventional (non-dialysis) ... The cruise, dubbed the "2010 Freedom Cruise: ... Miami, Fla. on January 3, 2010 and returns ...
Breaking Medicine Technology:Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Zografia Receives Top Identity Award From Nashville AIGA 50522 1Triple S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico Inc 50520 1Triple S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico Inc 50520 2Triple S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico Inc 50520 3Triple S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico Inc 50520 4Dr Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro Health Enamel Shield 50518 1Dr Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro Health Enamel Shield 50518 2Dr Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro Health Enamel Shield 50518 3
... WIRE)--Jul 3, 2007 - EPIX,Pharmaceuticals, Inc. (NASDAQ:EPIX) today ... officer of EPIX, is,scheduled to present at the ... July 10, 2007 at 1:30 p.m.,(EDT) at the ... presentation will be webcast live and can be ...
... July 03, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. ... President,Corporate Development and Finance, will present a ... Emerging Growth Conference on July 12,2007 at ... NY. , Interested parties may access the ...
Other Medicine Technology:EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference 2Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin,Emerging Growth Conference 2
... is a full-featured product capable of ... of the ophthalmic practice. This fully ... financial, administrative and clinical management needs ... as a scaleable solution, VersaVision can ...
... There is an important movement in ... access for handicapped persons. In fact, recent ... provides both. This ingenious device affords your ... your lane of equipment without having to ...
... ReSeeVit 5Z slit lamp is designed ... imaging. This video-ready slit lamp offers ... It is another addition to the ... offers the best products on the ...
... the newest and most advanced automated immunoassay ... AIA-1800 launches with a full menu of ... reproductive, cardiac, and anemia assays. ,The AIA-1800 ... primary tube sampling, auto dilution, auto pretreatment, ...
Medicine Products: